Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Cα

Clinical Cancer Research

Volumn 7, Issue 10, 2001, Pages 3156-3165

  Chisamore, Michael J ^a   Ahmed, Yasmin ^a   Jordan, V Craig ^a   Tonetti, Debra A ^a   Bentrem, David J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; PROGESTERONE RECEPTOR; PROTEIN KINASE C; TAMOXIFEN;

ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CELL PROLIFERATION; CELL STRAIN MCF 7; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUDE MOUSE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; ISOENZYMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RECEPTORS, ESTROGEN; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034792172     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Possible mechanisms in the emergence of tamoxifen-resistant breast cancer
2. 2+-dependent protein kinase of human mammary carcinoma cells: Inverse relationship to estrogen receptors
3. 2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance
4. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity
5. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo
6. Protein kinase C isozymes and the regulation of diverse cell responses
7. Protein kinase C and lipid signaling for sustained cellular responses
8. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
9. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
10. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
11. Protein kinase C isozymes differentially regulate promoters containing PEA-3/12-O-tetradecanoylphorbol-13-acetate response element motifs
12. Functional divergence of protein kinase C (PKC) family members. PKC γ differs from PKC α and -β II and nPKC ε in its competence to mediate-12-O-tetradecanoyl phorbol 13-acetate (TPA)-responsive transcriptional activation through a TPA-response element
13. Stable transfection of protein kinase C α cDNA in hormone-dependent breast cancer cell lines
14. Induction of a less aggressive breast cancer phenotype by protein kinase c-α and -β overexpression
15. MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype
16. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice
17. Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation
18. Activation and inhibition of the AP-1 complex in human breast cancer cells
19. ICI 182, 780 (Faslodex): Development of a novel, "pure" antiestrogen
20. Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: Involvement of the estrogen receptor
21. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
22. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
23. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue
24. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue
25. Direct evidence that the kinase activity of protein kinase C is involved in transcriptional activation through a TPA-responsive element
26. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice
27. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines
28. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
29. Expression of estrogen receptor-β in human breast tumors
30. Expression and regulation of estrogen receptor β in human breast tumors and cell lines
31. Characterization of the T61 human breast carcinoma established in nude mice
32. Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variants
33. Identification of human estrogen-inducible transcripts that potentially mediate the apoptotic response in breast cancer
34. Estrogen induces apoptosis in human breast cancer cells adapted to long term estrogen deprivation
35. Altered phenotypic characteristics of T47d human breast cancer cells after prolonged growth in estrogen-deficient medium
36. Comparison of efficacy and tolerability of fulvestrant (Faslodex™) with Anastrozole (Arimidex™) in post-menopausal (PM) women with advanced breast cancer (ABC) - Preliminary results
37. Antiestrogen ICI 164, 384 reduces cellular estrogen receptor content by increasing its turnover
38. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer
39. Diethylstilbestrol revisited in advanced breast cancer management